Page last updated: 2024-08-24

azelaic bishydroxamic acid and c & b metabond

azelaic bishydroxamic acid has been researched along with c & b metabond in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burgess, AJ; Gabrielli, BG; Hunter, LJ; Musgrove, EA; Parsons, PG; Pavey, S; Piva, TJ; Saunders, N; Warrener, R	1

Other Studies

1 other study(ies) available for azelaic bishydroxamic acid and c & b metabond

Article	Year
Up-regulation of p21(WAF1/CIP1) by histone deacetylase inhibitors reduces their cytotoxicity. Molecular pharmacology, 2001, Volume: 60, Issue:4 Topics: Apoptosis; Boron Compounds; Cell Cycle; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Enzyme Inhibitors; HeLa Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Methacrylates; Methylmethacrylates; Tumor Cells, Cultured; Up-Regulation	2001

Article

Year

Up-regulation of p21(WAF1/CIP1) by histone deacetylase inhibitors reduces their cytotoxicity.

Molecular pharmacology, 2001, Volume: 60, Issue:4

Topics: Apoptosis; Boron Compounds; Cell Cycle; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Enzyme Inhibitors; HeLa Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Methacrylates; Methylmethacrylates; Tumor Cells, Cultured; Up-Regulation

2001